Endoscopic pancreatic function testing assesses exocrine insufficiency and chronic pancreatitis. Indirect pancreatic function tests have limited sensitivity and specificity in early disease stages. Magnetic resonance cholangiopancreatography shows promise in detecting early changes as a direct measure of pancreatic function. This article summarizes the evolution of pancreatic function testing and highlights areas for future research, such as development of diagnostic biomarkers to stratify disease severity and targeted therapies to retard disease progression.
|Number of pages||8|
|Journal||Gastrointestinal Endoscopy Clinics of North America|
|State||Published - Oct 2018|
Bibliographical noteFunding Information:
Disclosures: In-kind support for investigator-initiated grant from ChiRhoClin, Inc was received for the MR study (M. Abu-El-Haija). The National Pancreas Foundation funded parts of the Pancreatic Function Studies using MRI (M. Abu-El-Haija). This study was supported by the National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases under award number U01DK108327 (D.L. Conwell). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
© 2018 Elsevier Inc.
- Chronic pancreatitis
- Endoscopic function testing
- Pancreatic function testing
- Pancreatic insufficiency
ASJC Scopus subject areas